Medical Incubator Japan


We are committed to seeking out, investing in, and supporting the growth of healthcare startups with cutting-edge technologies that could change the current standard of care and bring new value to patients.

We believe that successful investments must bring benefits for all investors and patients.

President / CEOJun KATSURA

President / CEOJun KATSURA

Investment Policy

Target Companies

  • ・Biotechs developing the first-in-class or best-in-class pharmaceuticals, covering from the latest technologies such as regenerative medicine and gene therapy to new chemical entities.
  • ・Biotechs developing devices, digital health, and AI technologies that bring innovation to medical support to patients.

Target Regions

Europe, North America and Japan, with focusing on the UK and Israel.

Investment Stage

All stages are considerable, mainly focusing on series A and B.